ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 176 filers reported holding ACORDA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,197,000 | +138.5% | 234,355 | +288.1% | 0.01% | +120.0% |
| Q4 2015 | $2,598,000 | +41.0% | 60,383 | -13.1% | 0.01% | +66.7% |
| Q3 2015 | $1,843,000 | -17.9% | 69,508 | +3.2% | 0.00% | -25.0% |
| Q2 2015 | $2,244,000 | +32.0% | 67,332 | +31.8% | 0.00% | +33.3% |
| Q1 2015 | $1,700,000 | -28.1% | 51,086 | -12.2% | 0.00% | -25.0% |
| Q4 2014 | $2,365,000 | -70.8% | 58,192 | -75.7% | 0.00% | -71.4% |
| Q3 2014 | $8,109,000 | +68.2% | 239,346 | +49.5% | 0.01% | +75.0% |
| Q2 2014 | $4,820,000 | +280.7% | 160,063 | +338.6% | 0.01% | +300.0% |
| Q1 2014 | $1,266,000 | +70.6% | 36,497 | +68.7% | 0.00% | +100.0% |
| Q3 2013 | $742,000 | -6.0% | 21,639 | -9.6% | 0.00% | 0.0% |
| Q2 2013 | $789,000 | – | 23,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |